FOSRENOL Side Effects

7021897-5 | Amputation
on Sep 22, 2010 Male patient from UNITED STATES , 87 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: amputation. Fosrenol dosage: . Patient was hospitalized.

7009538-4 | Diverticular Perforation, Peritonitis, Sepsis
Patient was taking Fosrenol (View Usage). Patient had the following side effects: diverticular perforation, peritonitis, sepsis (What is sepsis?) on Sep 16, 2010 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: Unk, Total Daily Dose Of 1500 Mg. During the same period patient was treated with PYRINAZIN (View Pyrinazin Review and Pyrinazin Label ), PENTCILLIN (View Pentcillin Review and Pentcillin Label ), ZOVIRAX /00587301/ (View Zovirax /00587301/ Review and Zovirax /00587301/ Label ), ARTIST (View Artist Review and Artist Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CONIEL (View Coniel Review and Coniel Label ), ALEROFF (View Aleroff Review and Aleroff Label ), POLARAMINE (View Polaramine Review and Polaramine Label ).

7009537-2 | Aspiration, X-ray Abnormal
Adverse event was reported on Sep 14, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: ) was diagnosed with hyperphosphataemia and. Location: JAPAN , 66 years of age, After Fosrenol was administered, patient had the following side effects: aspiration, x-ray abnormal. Patient was hospitalized.

7007123-1 | Aspiration, Chest X-ray Abnormal
on Sep 15, 2010 Female patient from JAPAN , 82 years of age, was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, chest x-ray abnormal. Fosrenol dosage: .


7002634-7 | Diverticulitis, X-ray Abnormal
on Sep 17, 2010 Female patient from SPAIN , 75 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: diverticulitis, x-ray abnormal. Fosrenol dosage: . Patient was hospitalized.

7001585-1 | Fluid Overload
Patient was taking Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: fluid overload on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 140.0 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: . Patient was hospitalized.

6999304-8 | Blood Glucose Increased, Cholelithiasis, Diarrhoea, Gastrooesophageal Reflux Disease, Liver Function Test Abnormal
Adverse event was reported on Sep 10, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 1000 Mg With Meals, Other) was diagnosed with hyperphosphataemia, diabetes mellitus, hypertension and. Location: UNITED STATES , weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, cholelithiasis, diarrhoea, gastrooesophageal reflux disease, liver function test abnormal. During the same period patient was treated with INSULIN NPH /01223208/ (24 Iu At Night, 1x/day:qd) (View Insulin Nph /01223208/ Review and Insulin Nph /01223208/ Label ), NOVOLOG (Unk Iu, As Req'd) (View Novolog Review and Novolog Label ), CARVEDILOL (12.5 Mg, 1x/day:qd) (View Carvedilol Review and Carvedilol Label ), AMLODIPINE (5 Mg, 1x/day:qd) (View Amlodipine Review and Amlodipine Label ), LISINOPRIL (20 Mg, 2x/day:bid) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6992616-3 | Diverticular Perforation, Peritonitis, Sepsis
on Sep 13, 2010 Female patient from JAPAN , 85 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: diverticular perforation, peritonitis, sepsis (What is sepsis?). Fosrenol dosage: Unk, Total Daily Dose Of 1500 Mg.

6991634-9 | Abdominal Distension, Gastric Ulcer
on Sep 08, 2010 Female patient from UNITED STATES , weighting 179.7 lb, was diagnosed with hyperphosphataemia, dialysis (What is dialysis?) and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: abdominal distension, gastric ulcer. Fosrenol dosage: 1000 Mg, 3x/day:tid With Meals. Patient was hospitalized.

6991633-7 | Panic Attack
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: panic attack on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: Unk Mg, Other (with Meals). During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6987793-4 | Nausea
Adverse event was reported on Sep 13, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: ) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 48 years of age, Patient had the following side effects: nausea (What is nausea?).

6980474-2 | Cardiac Arrest
on Sep 09, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Fosrenol dosage: Unk Mg, Other (with Meals).

6978812-X | Abdominal Infection, Gallbladder Disorder
on Sep 09, 2010 Male patient from UNITED STATES , 68 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal infection, gallbladder disorder. Fosrenol dosage: 500 Mg, Other (with Meals). During the same period patient was treated with PHOSLO (2031 Mg, Other (three 677 Mg Capsules With Meals)) (View Phoslo Review and Phoslo Label ).

6977896-2 | Cerebral Haemorrhage, Nausea
Patient was taking Fosrenol (View Usage). Patient had the following side effects: cerebral haemorrhage, nausea (What is nausea?) on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 140.0 lb, was diagnosed with nephropathy, hyperphosphataemia, hypertension, gastric disorder, cardiovascular event prophylaxis, diabetes mellitus, blood cholesterol and. Fosrenol dosage: 1000 Mg, 3x/day:tid. During the same period patient was treated with CLONIDINE (10 Mg, 3x/day:tid) (View Clonidine Review and Clonidine Label ), NORVASC (10 Mg, 1x/day:qd) (View Norvasc Review and Norvasc Label ), PROTONIX (10 Mg, 1x/day:qd) (View Protonix Review and Protonix Label ), METOPROLOL TARTRATE (50 Mg, 2x/day:bid) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), NOVOLOG (Unk, 1x/day:qd (sliding Scale)) (View Novolog Review and Novolog Label ), SIMVASTATIN (40 Mg, 1x/day:qd) (View Simvastatin Review and Simvastatin Label ), LANTUS /01483501/ (16 Iu, 1x/day:qd) (View Lantus /01483501/ Review and Lantus /01483501/ Label ). Patient was hospitalized.

6977893-7 | Constipation, Renal Failure
Adverse event was reported on Sep 01, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 500 Mg After Each Meal And Snack) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , weighting 183.0 lb, After Fosrenol was administered, patient had the following side effects: constipation (What is constipation?), renal failure.

6975345-1 | Calcinosis, Hypertension
on Sep 01, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with hyperphosphataemia, diabetes mellitus, dialysis (What is dialysis?) and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: calcinosis, hypertension. Fosrenol dosage: . During the same period patient was treated with LANTUS /01483501/ (18 Iu, 1x/day:qd) (View Lantus /01483501/ Review and Lantus /01483501/ Label ), NOVOLIN R (Unk Iu, As Req'd) (View Novolin R Review and Novolin R Label ), SENSIPAR (60 Mg, 1x/day:qd) (View Sensipar Review and Sensipar Label ), NEPHROCAPS (Unk, 1x/day:qd) (View Nephrocaps Review and Nephrocaps Label ), NEURONTIN (100 Mg, 1x/day:qd) (View Neurontin Review and Neurontin Label ), CELEXA (20 Mg, 1x/day:qd) (View Celexa Review and Celexa Label ), ZOCOR (80 Mg, 1x/day:qd) (View Zocor Review and Zocor Label ), ASPIRIN (81 Mg, 1x/day:qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6965172-3 | Surgery
on Aug 31, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: surgery (What is surgery?). Fosrenol dosage: 1000 Mg, With Meals. Patient was hospitalized.

6964986-3 |
Patient was taking Fosrenol (View Usage). on Aug 31, 2010 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg, 3x/day:tid, With Meals. During the same period patient was treated with CALCIUM ACETATE (667 Mg, Other, With Each Meal) (View Calcium Acetate Review and Calcium Acetate Label ).

6963092-1 |
Adverse event was reported on Aug 31, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 1000 Mg, 3x/day:tid With Meals) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , weighting 167.6 lb, . During the same period patient was treated with APRESOLINE (50 Mg, Other, 2 Tablets 3x/day: Tid) (View Apresoline Review and Apresoline Label ), ISORDIL TEMBIDS (30 Mg, 1x/day:qd) (View Isordil Tembids Review and Isordil Tembids Label ), AVAPRO (300 Mg, 1x/day:qd) (View Avapro Review and Avapro Label ), LOPRESSOR (25 Mg, 1x/day:qd) (View Lopressor Review and Lopressor Label ).

6960113-7 | Abdominal Pain, Constipation, X-ray Abnormal
on Aug 26, 2010 Female patient from SPAIN , weighting 131.2 lb, was diagnosed with renal osteodystrophy, hypoparathyroidism secondary, diabetes mellitus, hypertension, ischaemic cardiomyopathy and was treated with Fosrenol (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), x-ray abnormal. Fosrenol dosage: 750 Mg, 3x/day:tid. During the same period patient was treated with MIMPARA /01735301/ (30 / 48h) (View Mimpara /01735301/ Review and Mimpara /01735301/ Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), LOSARTAN (12.5 Unk, 1x/day:qd) (View Losartan Review and Losartan Label ), UNIKET (20 Unk, 2x/day:bid) (View Uniket Review and Uniket Label ).

6957767-8 | Diarrhoea, Pneumonia, Vascular Rupture
on Aug 25, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with hyperphosphataemia, diabetes mellitus, blood pressure increased, blood cholesterol increased, cardiac disorder and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: diarrhoea, pneumonia (What is pneumonia?), vascular rupture. Fosrenol dosage: 1000 Mg, With Meals Or Snacks. During the same period patient was treated with RAMIPRIL (7 Mg, 2x/day:bid) (View Ramipril Review and Ramipril Label ), TRICOR (145 Mg, 1x/day:qd) (View Tricor Review and Tricor Label ), TEKTURNA (150 Mg, 1x/day:qd) (View Tekturna Review and Tekturna Label ), METOPROLOL TARTRATE (25 Mg, 1x/day:qd) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PRAVASTATIN (40 Mg, 1x/day:qd) (View Pravastatin Review and Pravastatin Label ), HUMULIN 70/30 (70/30 Mix 35 Iu, 1x/day:qd In Morning) (View Humulin 70/30 Review and Humulin 70/30 Label ). Patient was hospitalized.

6957478-9 |
Patient was taking Fosrenol (View Usage). on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg, 2x/day:bid With Meals. During the same period patient was treated with SENSIPAR (View Sensipar Review and Sensipar Label ).

6941788-5 | Adverse Event, Fall, Product Quality Issue, Therapeutic Response Unexpected, Traumatic Fracture
Adverse event was reported on Aug 17, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 1000 Mg, 3x/day:tid With Meals) was diagnosed with hyperphosphataemia, neuropathy peripheral, cardiac disorder, thyroid disorder, vitamin supplementation, faecaloma and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: adverse event, fall (What is fall?), product quality issue, therapeutic response unexpected, traumatic fracture. During the same period patient was treated with LYRICA (50 Mg, 1x/day:qd) (View Lyrica Review and Lyrica Label ), ASPIRIN (325 Mg, 1x/day:qd) (View Aspirin Review and Aspirin Label ), PLAVIX (75 Mg, 1x/day:qd) (View Plavix Review and Plavix Label ), LEVOTHYROXINE (25 Ug, 1x/day:qd) (View Levothyroxine Review and Levothyroxine Label ), RENAL (View Renal Review and Renal Label ), STOOL SOFTENER (View Stool Softener Review and Stool Softener Label ), MIRALAX (View Miralax Review and Miralax Label ). Patient was hospitalized.

6941786-1 | Ileus
on Aug 19, 2010 Male patient from JAPAN , 53 years of age, was diagnosed with hyperphosphataemia, diabetes mellitus, hypertension, osteoporosis (What is osteoporosis?) and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: ileus. Fosrenol dosage: . During the same period patient was treated with BASEN (.9 Mg, Unk) (View Basen Review and Basen Label ), INSULIN (View Insulin Review and Insulin Label ), NORVASC (10 Mg, Unk) (View Norvasc Review and Norvasc Label ), ROCALTROL (.25 Ug, Unk) (View Rocaltrol Review and Rocaltrol Label ), DOXAZOSIN MESYLATE (1 Mg, Unk) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

6938014-X | Renal Impairment
on Aug 16, 2010 Male patient from UNITED STATES , weighting 110.0 lb, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: renal impairment. Fosrenol dosage: 1000 Mg, 3x/day:tid With Meals. Patient was hospitalized.

6774380-6 | Gastrointestinal Hypomotility
Patient was taking Fosrenol (View Usage). Patient had the following side effects: gastrointestinal hypomotility on Jun 14, 2010 from SPAIN Additional patient health information: Male patient , 75 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: . Patient was hospitalized.

6751379-7 | Intestinal Obstruction
Adverse event was reported on Jun 01, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: ) was diagnosed with hyperphosphataemia and. Location: SPAIN , 72 years of age, After Fosrenol was administered, patient had the following side effects: intestinal obstruction. Patient was hospitalized.

6739331-9 | Decreased Appetite, Graft Infection
on Sep 24, 2009 Male patient from UNITED STATES , 47 years of age, weighting 155.0 lb, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, graft infection. Fosrenol dosage: 2000 Mg, 3x/day:tid With Meals, Oral ; 2000 Mg, 3x/day:tid With Meals, Oral. During the same period patient was treated with METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6739330-7 | Hypotension
on Jul 20, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: hypotension. Fosrenol dosage: 1000 Mg, With Breakfast And Dinner, Oral. Patient was hospitalized.

6739327-7 | Hypotension
Patient was taking Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: hypotension on Jul 30, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 203.0 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg, 3x/day:tid, Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6739326-5 | Abdominal Pain Upper
Adverse event was reported on Jun 09, 2009 by a Male patient taking Fosrenol (View Usage) (Dosage: 1000 Mg, 3x/day:tid, Oral) was diagnosed with renal failure chronic and. Location: UNITED STATES , 65 years of age, weighting 183.9 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), AVAPRO (View Avapro Review and Avapro Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METROCAPS (METRONIDAZOLE) (View Metrocaps (metronidazole) Review and Metrocaps (metronidazole) Label ). Patient was hospitalized.

6739324-1 | Hypoaesthesia, Medical Device Complication, Nausea
on Apr 29, 2009 Female patient from UNITED STATES , 76 years of age, weighting 218.0 lb, was diagnosed with nephropathy and was treated with Fosrenol (View Usage). Patient had the following side effects: hypoaesthesia, medical device complication, nausea (What is nausea?). Fosrenol dosage: Oral. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

6739323-X | Hypotension, Malaise
on Mar 09, 2010 Female patient from UNITED STATES , 87 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: hypotension, malaise. Fosrenol dosage: 1000 Mg, With Each Meal, Oral.

6739322-8 | Abdominal Pain Upper
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper on Feb 22, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: . Patient was hospitalized.

6739304-6 | Arteriovenous Fistula Occlusion, Nausea
Adverse event was reported on Oct 09, 2009 by a Female patient taking Fosrenol (View Usage) (Dosage: 1000 Mg, 3xday:tid With Food, Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 43 years of age, weighting 151.9 lb, Patient had the following side effects: arteriovenous fistula occlusion, nausea (What is nausea?). During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6739302-2 | Abdominal Discomfort, Dehydration, Hypotension, Vomiting
on Mar 17, 2010 Female patient from UNITED STATES , 58 years of age, weighting 160.1 lb, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: abdominal discomfort, dehydration, hypotension, vomiting. Fosrenol dosage: Takes One And And One-half 1000 Mg. Tablets With Meals, Oral ; 1000 Mg, 3x/day:tid With Meals, Oral. During the same period patient was treated with LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), ZEMPLAR (View Zemplar Review and Zemplar Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TYLENOL /00020001/ (PARACETAMOL) (View Tylenol /00020001/ (paracetamol) Review and Tylenol /00020001/ (paracetamol) Label ), TYLENOL PM /00435101/ (DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL) (View Tylenol Pm /00435101/ (diphenhydramine Hydrochloride, Paracetamol) Review and Tylenol Pm /00435101/ (diphenhydramine Hydrochloride, Paracetamol) Label ).

6727207-2 | Diverticulitis, Enterococcal Sepsis, X-ray Abnormal
on May 08, 2010 Male patient from SPAIN , weighting 144.4 lb, was diagnosed with hyperphosphataemia, hyperparathyroidism secondary, diabetes mellitus, hypertension and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: diverticulitis, enterococcal sepsis, x-ray abnormal. Fosrenol dosage: 1000 Mg, 3x/day:tid. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), ENALAPRIL MALEATE (20 Mg, 1x/day:qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), BISOPROLOL (5 Mg, 1x/day:qd) (View Bisoprolol Review and Bisoprolol Label ), AMLODIPIN /00972401/ (10 Mg, 1x/day:qd) (View Amlodipin /00972401/ Review and Amlodipin /00972401/ Label ), DOXAZOSIN MESYLATE (4 Mg, 1x/day:qd) (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), SEVELAMER (1600 Mg, 3x/day:tid) (View Sevelamer Review and Sevelamer Label ), CALCIUM ACETATE (500 Mg, 2x/day:bid) (View Calcium Acetate Review and Calcium Acetate Label ). Patient was hospitalized.

6717713-9 |
Patient was taking Fosrenol (View Usage). on Apr 26, 2010 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg With Meals And Snacks, Oral.

6717592-X | Device Malfunction, Dialysis, Loss Of Consciousness, Myocardial Infarction, Treatment Noncompliance
Adverse event was reported on Apr 27, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: 1000 Mg After Every Meal, Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 71 years of age, weighting 168.9 lb, After Fosrenol was administered, patient had the following side effects: device malfunction, dialysis (What is dialysis?), loss of consciousness, myocardial infarction, treatment noncompliance. During the same period patient was treated with PHOSLO (View Phoslo Review and Phoslo Label ). Patient was hospitalized.

6717589-X | Cerebrovascular Accident, Diabetic Complication, Diarrhoea, Flatulence, Mastication Disorder, Treatment Noncompliance
on Apr 27, 2010 Male patient from UNITED STATES , 41 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, diabetic complication, diarrhoea, flatulence, mastication disorder, treatment noncompliance. Fosrenol dosage: Mg,(506doses Weekly) Other, Oral. Patient was hospitalized.

6717584-0 |
on Apr 28, 2010 Female patient from UNITED KINGDOM , 84 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). . Fosrenol dosage: Oral.

6717580-3 |
Patient was taking Fosrenol (View Usage). on Apr 27, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg With Each Meal, Oral.

6710405-1 | Enterococcal Sepsis, Product Solubility Abnormal, X-ray Abnormal
Adverse event was reported on Apr 21, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: 3000 Mg, Total Daily Dose, Oral) was diagnosed with hyperphosphataemia and. Location: SPAIN , 58 years of age, Patient experienced the following unwanted or unexpected effects: enterococcal sepsis, product solubility abnormal, x-ray abnormal. Patient was hospitalized.

6710270-2 | Gastric Ulcer Haemorrhage, Upper Respiratory Tract Inflammation
on Apr 28, 2010 Male patient from JAPAN , 41 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: gastric ulcer haemorrhage, upper respiratory tract inflammation. Fosrenol dosage: See Image. During the same period patient was treated with CELECOXIB (200 Mg, Total Daily Dose, Oral) (View Celecoxib Review and Celecoxib Label ), CALTAN (CALCIUM CARBONATE) (View Caltan (calcium Carbonate) Review and Caltan (calcium Carbonate) Label ), OXAROL (MAXACALCITROL) (View Oxarol (maxacalcitrol) Review and Oxarol (maxacalcitrol) Label ), CINACALCET HYDROCHLORIDE (CINACALCET HYDROCHLORIDE) (View Cinacalcet Hydrochloride (cinacalcet Hydrochloride) Review and Cinacalcet Hydrochloride (cinacalcet Hydrochloride) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PLETAL (View Pletal Review and Pletal Label ), NEOMALLERMIN TR (CHLORPHENARAMINE MALEATE) (View Neomallermin Tr (chlorphenaramine Maleate) Review and Neomallermin Tr (chlorphenaramine Maleate) Label ). Patient was hospitalized.

6710266-0 | Diabetic Foot Infection
on Apr 27, 2010 Male patient from UNITED STATES , 68 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: diabetic foot infection. Fosrenol dosage: Mg, Oral. Patient was hospitalized.

6710252-0 | Anaemia, Asthenia, Dialysis, Loss Of Consciousness
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, dialysis (What is dialysis?), loss of consciousness on Apr 27, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 104.9 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 500 Mg With Each Meal, Oral, 1000 Mg With Each Meal, Oral. Patient was hospitalized.

6709337-4 | Anaphylactic Reaction, Blood Pressure Increased, Cardiac Failure Acute, Cardiomegaly, Chest Discomfort, Palpitations, Pulmonary Oedema
Adverse event was reported on Apr 26, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 250 Mg, One Dose, Oral) was diagnosed with hyperphosphataemia and. Location: JAPAN , 57 years of age, Patient had the following side effects: anaphylactic reaction, blood pressure increased, cardiac failure acute, cardiomegaly, chest discomfort, palpitations, pulmonary oedema. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6709007-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal
on Apr 22, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. Fosrenol dosage: See Image. During the same period patient was treated with CALTAN (CALCIUM CARBONATE) (View Caltan (calcium Carbonate) Review and Caltan (calcium Carbonate) Label ), ZYLORIC /00003301/ (View Zyloric /00003301/ Review and Zyloric /00003301/ Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), NESP (DARBEPOETIN ALFA) (View Nesp (darbepoetin Alfa) Review and Nesp (darbepoetin Alfa) Label ), FESIN (SACCHARATED IRON OXIDE) (View Fesin (saccharated Iron Oxide) Review and Fesin (saccharated Iron Oxide) Label ).

6706186-8 | Blood Phosphorus Increased, Clostridial Infection, Dehydration, Scrotal Infection
on Apr 26, 2010 Male patient from UNITED STATES , 68 years of age, weighting 254.0 lb, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: blood phosphorus increased, clostridial infection, dehydration, scrotal infection. Fosrenol dosage: 1500 Mg With Meals, Oral. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), PROVEXCV (BIOFLAVONOIDS, BROMELAINS, GINKGO BILOBA, PAPAIN, VACCINIUM (View Provexcv (bioflavonoids, Bromelains, Ginkgo Biloba, Papain, Vaccinium Review and Provexcv (bioflavonoids, Bromelains, Ginkgo Biloba, Papain, Vaccinium Label ), PHYTOMEGA (ASCORBIC ACID, BROMELAINS, FATS NOS, FISH OIL, LECITHIN, SI (View Phytomega (ascorbic Acid, Bromelains, Fats Nos, Fish Oil, Lecithin, Si Review and Phytomega (ascorbic Acid, Bromelains, Fats Nos, Fish Oil, Lecithin, Si Label ). Patient was hospitalized.

6706180-7 | Device Malfunction, Myocardial Infarction, Treatment Noncompliance
Patient was taking Fosrenol (View Usage). Patient had the following side effects: device malfunction, myocardial infarction, treatment noncompliance on Apr 23, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 168.9 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg After Every Meal, Oral. During the same period patient was treated with PHOSLO (View Phoslo Review and Phoslo Label ). Patient was hospitalized.